B6.129P2-Cd19tm1(cre)Cgn/Cnrm
Status | Available to order |
EMMA ID | EM:02077 |
International strain name | B6.129P2-Cd19tm1(cre)Cgn/Cnrm |
Alternative name | B6-CD19-Cre |
Strain type | Targeted Mutant Strains : Knock-in |
Allele/Transgene symbol | Cd19tm1(cre)Cgn, |
Gene/Transgene symbol | Cd19 |
Information from provider
Provider | Klaus Rajeswky |
Provider affiliation | Harvard Medical School |
Genetic information | Original targeted mutation for the specific expression of cre recombinase in B-lymphocytes throughout development and differentiation. In-frame insertion of a cre recombinase gene into the first coding exon of the Cd19 gene, followed by an frt-flanked neomycin cassette. The endogenous Cd19 promoter drives the cre recombinase expression. |
Phenotypic information | Original strain for cre recombinase expression throughout B-lymphocyte development and differentiation. Heterozygous mice are normal and can be crossed to mice carrying floxed gene targets, for specific in vivo deletion in B-lymphocytes. |
Breeding history | Backcrossed to C57BL/6 (10 generations) |
References |
|
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Common variable immunodeficiency / Orphanet_1572
MGI phenotypes (allele matching)
Literature references
- B lymphocyte-specific, Cre-mediated mutagenesis in mice.;Rickert R C, Roes J, Rajewsky K, ;1997;Nucleic acids research;25;1317-8; 9092650
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).